ROSEWELL Trademark

Trademark Overview


On Wednesday, July 17, 2024, a trademark application was filed for ROSEWELL with the United States Patent and Trademark Office. The USPTO has given the ROSEWELL trademark a serial number of 98654038. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 4, 2025. This trademark is owned by RoseWell Pharmaceuticals LLC. The ROSEWELL trademark is filed in the Pharmaceutical Products category with the following description:

Analgesics; Antihistamines; Aspirin; Decongestants; Expectorants; Allergy medications; Allergy relief medication; Analgesic preparations; Analgesic and anti-inflammatory preparations; Anti-tussive expectorants; Antiallergic medicines; Cough drops; Cough expectorants; Cough lozenges; Cough pastilles for medical use; Cough syrups; Cough syrups for medical use; Cough treatment preparations; Decongestant capsules; Decongestant nasal sprays; Ibuprofen for use as an oral analgesic; Medicated lozenges; Non-medicated topical gel for the prevention and treatment of cold and flu; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations for the treatment and prevention of acne and pimples; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Preparations for treating co...
rosewell

General Information


Serial Number98654038
Word MarkROSEWELL
Filing DateWednesday, July 17, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements


Goods and ServicesAnalgesics; Antihistamines; Aspirin; Decongestants; Expectorants; Allergy medications; Allergy relief medication; Analgesic preparations; Analgesic and anti-inflammatory preparations; Anti-tussive expectorants; Antiallergic medicines; Cough drops; Cough expectorants; Cough lozenges; Cough pastilles for medical use; Cough syrups; Cough syrups for medical use; Cough treatment preparations; Decongestant capsules; Decongestant nasal sprays; Ibuprofen for use as an oral analgesic; Medicated lozenges; Non-medicated topical gel for the prevention and treatment of cold and flu; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations for the treatment and prevention of acne and pimples; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Preparations for treating colds; Anti-cough drops; Oral analgesics; Topical analgesics
Pseudo MarkROSE WELL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoseWell Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92128-2538

Party NameRoseWell Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92128-2538

Trademark Events


Event DateEvent Description
Thursday, July 18, 2024NEW APPLICATION ENTERED
Thursday, February 6, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 7, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 7, 2025ASSIGNED TO EXAMINER
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION